EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)Randomisierte kontrollierte StudieOpen Access

Efficacy of the Dapivirine Vaginal Ring Accounting for Imperfect Adherence

Marla J Husnik, Renee Heffron, James P Hughes, Barbra Richardson, Ariane van der Straten, Thesla Palanee-Phillips, Lydia Soto-Torres, Devika Singh, Brenda Gati Mirembe, Edward Livant, Zakir Gaffoor, Leila E Mansoor und 5 weitere

AIDS and Behavior · 2024

DOI: 10.1007/s10461-024-04463-3 ↗

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift AIDS and Behavior, 2024. Verfasst von Marla J Husnik und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, University of Washington, Seattle, WA, USA. Hauptthemen laut MEDLINE: HIV Infections, Pyrimidines, Contraceptive Devices, Female, Anti-HIV Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Product adherence is critical to obtaining objective estimates of efficacy of pre-exposure prophylactic interventions against HIV-1 infection. With imperfect adherence, intention-to-treat analyses assess the collective effects of complete, sub-optimal and non-adherence, providing a biased and attenuated estimate of the average causal effect of an intervention. Using data from the MTN-020/ASPIRE phase III trial evaluating HIV-1 efficacy of the dapivirine vaginal ring, we conducted per-protocol, and adherence-adjusted causal inference analyses using principal stratification and marginal structural models. We constructed two adherence cut offs of ≥ 0.9 mg (low cutoff) and > 4.0 mg (high cutoff) that represent drug released from the ring over a 28-day period. The HIV-1 efficacy estimate (95% CI) was 30.8% (3.6%, 50.3%) (P = 0.03) from the per-protocol analysis, and 53.6% (16.5%, 74.3%) (P = 0.01) among the highest predicted adherers from principal stratification analyses using the low cutoff. Marginal structural models produced efficacy estimates (95% CIs) ranging from 48.8 (21.8, 66.4) (P = 0.0019) to 56.5% (32.8%, 71.9%) (P = 0.0002). Application of adherence-adjusted causal inference methods are useful in interpreting HIV-1 efficacy in secondary analyses of PrEP clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsPyrimidinesContraceptive Devices, FemaleAnti-HIV AgentsHIV-1HumansFemaleAdultPre-Exposure ProphylaxisTreatment OutcomeIntention to Treat AnalysisDrug Monitoring

Stichwörter der Autor:innen

Causal inferenceDapivirineEfficacyHIV-1 preventionIntravaginal ringNon-adherence

Substanzen

DapivirinePyrimidinesAnti-HIV Agents

Autor:innen und Institutionen

  • Department of Epidemiology, University of Washington, Seattle, WA, USA.
  • Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Department of Global Health, University of Washington, Seattle, WA, USA.
  • Department of Biostatistics, University of Washington, Seattle, WA, USA.
  • Department of Medicine, The Center for AIDS Prevention Studies, University of California San Francisco, San Francisco, CA, USA.
  • ASTRA Consulting, Kensington, CA, USA.

Förderung

  • Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases
  • NIAID NIH HHS

Zitieren

APA

Husnik, M. J., Heffron, R., Hughes, J. P., Richardson, B., van der Straten, A., Palanee-Phillips, T., Soto-Torres, L., Singh, D., Mirembe, B. G., Livant, E., Gaffoor, Z., Mansoor, L. E., Siva, S. S., Dadabhai, S., Kiweewa, F. M., Baeten, J. M., & MTN-020/ASPIRE Study Team (2024). Efficacy of the Dapivirine Vaginal Ring Accounting for Imperfect Adherence. AIDS and Behavior. https://doi.org/10.1007/s10461-024-04463-3

Vancouver

Husnik MJ, Heffron R, Hughes JP, Richardson B, van der Straten A, Palanee-Phillips T, et al. Efficacy of the Dapivirine Vaginal Ring Accounting for Imperfect Adherence. AIDS and Behavior. 2024. doi:10.1007/s10461-024-04463-3

BibTeX
@article{Husnik2024,
  author = {Husnik, Marla J and Heffron, Renee and Hughes, James P and Richardson, Barbra and van der Straten, Ariane and Palanee-Phillips, Thesla and Soto-Torres, Lydia and Singh, Devika and Mirembe, Brenda Gati and Livant, Edward and Gaffoor, Zakir and Mansoor, Leila E and Siva, Samantha S and Dadabhai, Sufia and Kiweewa, Flavia Matovu and Baeten, Jared M and MTN-020/ASPIRE Study Team, MTN-020/ASPIRE Study Team},
  title = {Efficacy of the Dapivirine Vaginal Ring Accounting for Imperfect Adherence},
  journal = {AIDS and Behavior},
  year = {2024},
  doi = {10.1007/s10461-024-04463-3}
}
Kostenlos starten →